Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN53514546
ISRCTN53514546
Completed
未知

Controlled ovarian hyperstimulation with long versus conventional protocol of gonadotropin-releasing hormone (GnRH) antagonist in women with polycystic ovarian disease (PCOD) undergoing assisted reproduction: a randomized controlled trial

Hurley Medical Center (USA)0 sites140 target enrollmentAugust 26, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hurley Medical Center (USA)
Enrollment
140
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 26, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Hurley Medical Center (USA)

Eligibility Criteria

Inclusion Criteria

  • •1\. Women (age between 18\-40 years) with PCOS, undergoing assisted reproductive technology (ART). PCOS was defined according to Rotterdam criteria at least 2 of the following 3 features:
  • •1\.1\. Oligo and/or anovulation
  • •1\.2\. Clinical and/or biochemical signs of hyperandrogenism and
  • •1\.3\. Polycystic ovary on ultrasound scan (The Rotterdam ESHRE/ASRM\-sponsored PCOS consensus workshop group 2004\)

Exclusion Criteria

  • •1\. Hypothyroidism
  • •2\. Hyperprolactinemia
  • •3\. Non\-classical form of congenital adrenal hyperplasia
  • •4\. Cushing?s syndrome
  • •5\. Androgen\-secreting tumors

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
We propose a new controlled ovarian hyperstimulation (COH) protocol for polycystic ovary syndrome (PCOS).Polycystic ovary syndrome(PCOS)
JPRN-UMIN000045214Saint Mother Clinic50
Completed
Phase 4
NATural Ovarian StimulationInfertility
NCT02892942Assistance Publique - Hôpitaux de Paris129
Completed
Not Applicable
Controlled ovarian stimulation and intrauterine insemination or in vitro-fertilisation for the first line treatment of unexplained infertilityInfertilityBest first line treatment options for unexplained infertilityPregnancy and Childbirth
ISRCTN43430382Homerton University Hospital (UK)320
Completed
Not Applicable
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOS
IRCT201109163386N4Semnan University of Medical Sciences142
Unknown
Phase 2
Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVFInfertility
NCT02173977Sheba Medical Center200